HU9303025D0 - 4-aryl-3(jheteroaryl-ureido)-quinoline derivatives and pharmaceutical preparatives containing them - Google Patents
4-aryl-3(jheteroaryl-ureido)-quinoline derivatives and pharmaceutical preparatives containing themInfo
- Publication number
- HU9303025D0 HU9303025D0 HU9303025A HU9303025A HU9303025D0 HU 9303025 D0 HU9303025 D0 HU 9303025D0 HU 9303025 A HU9303025 A HU 9303025A HU 9303025 A HU9303025 A HU 9303025A HU 9303025 D0 HU9303025 D0 HU 9303025D0
- Authority
- HU
- Hungary
- Prior art keywords
- jheteroaryl
- ureido
- aryl
- quinoline derivatives
- preparatives containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69232391A | 1991-04-26 | 1991-04-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9303025D0 true HU9303025D0 (en) | 1994-01-28 |
HUT65748A HUT65748A (en) | 1994-07-28 |
Family
ID=24780107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9303025A HUT65748A (en) | 1991-04-26 | 1992-03-16 | Process for producing 4-aryl-3(heteroarylureido)-quinoline derivatives and pharmaceutical preparations containing them |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0590094A1 (en) |
JP (1) | JPH0776215B2 (en) |
CN (1) | CN1066068A (en) |
AU (1) | AU1879792A (en) |
BR (1) | BR9205939A (en) |
CA (1) | CA2108014A1 (en) |
CZ (1) | CZ395592A3 (en) |
DE (1) | DE9290049U1 (en) |
FI (1) | FI934710A0 (en) |
HU (1) | HUT65748A (en) |
IE (1) | IE921330A1 (en) |
IL (1) | IL101627A0 (en) |
MX (1) | MX9201916A (en) |
NO (1) | NO933837L (en) |
NZ (1) | NZ242493A (en) |
PT (1) | PT100426A (en) |
TW (1) | TW197436B (en) |
WO (1) | WO1992019614A1 (en) |
YU (1) | YU44592A (en) |
ZA (1) | ZA922976B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3323393A (en) * | 1992-01-23 | 1993-09-01 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
DE69633059T2 (en) * | 1995-05-31 | 2005-08-18 | Sumitomo Pharmaceuticals Co., Ltd. | NEW NAPHTHYRIDINE DERIVATIVES. |
WO1998023615A1 (en) * | 1996-11-26 | 1998-06-04 | Sumitomo Pharmaceuticals Company, Limited | Novel naphthyridine derivatives |
CA2321237A1 (en) | 1998-02-25 | 1999-09-02 | Masami Muraoka | Pyridone derivatives and process for producing the same |
US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
EP2284157A1 (en) * | 2003-12-12 | 2011-02-16 | Wyeth | Quinolines useful in treating cardiovascular disease |
CN103601677B (en) * | 2013-11-19 | 2015-11-18 | 清华大学 | Prepare the method for 2-alkylthio quinoline |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
WO1991004027A1 (en) * | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
TW205037B (en) * | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd |
-
1992
- 1992-03-16 HU HU9303025A patent/HUT65748A/en active IP Right Revival
- 1992-03-16 CZ CS923955A patent/CZ395592A3/en unknown
- 1992-03-16 WO PCT/US1992/001801 patent/WO1992019614A1/en not_active Application Discontinuation
- 1992-03-16 AU AU18797/92A patent/AU1879792A/en not_active Abandoned
- 1992-03-16 JP JP4510186A patent/JPH0776215B2/en not_active Expired - Lifetime
- 1992-03-16 CA CA002108014A patent/CA2108014A1/en not_active Abandoned
- 1992-03-16 DE DE9290049U patent/DE9290049U1/en not_active Expired - Lifetime
- 1992-03-16 EP EP92923349A patent/EP0590094A1/en not_active Withdrawn
- 1992-03-16 BR BR9205939A patent/BR9205939A/en not_active Application Discontinuation
- 1992-03-17 TW TW081102005A patent/TW197436B/zh active
- 1992-03-24 ZA ZA922976A patent/ZA922976B/en unknown
- 1992-04-16 IL IL101627A patent/IL101627A0/en unknown
- 1992-04-24 MX MX9201916A patent/MX9201916A/en not_active IP Right Cessation
- 1992-04-24 PT PT100426A patent/PT100426A/en not_active Application Discontinuation
- 1992-04-24 IE IE133092A patent/IE921330A1/en not_active Application Discontinuation
- 1992-04-24 YU YU44592A patent/YU44592A/en unknown
- 1992-04-24 NZ NZ242493A patent/NZ242493A/en unknown
- 1992-04-25 CN CN92103010A patent/CN1066068A/en active Pending
-
1993
- 1993-10-25 NO NO933837A patent/NO933837L/en unknown
- 1993-10-25 FI FI934710A patent/FI934710A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2108014A1 (en) | 1992-10-27 |
TW197436B (en) | 1993-01-01 |
HUT65748A (en) | 1994-07-28 |
NZ242493A (en) | 1994-08-26 |
JPH0776215B2 (en) | 1995-08-16 |
FI934710A (en) | 1993-10-25 |
WO1992019614A1 (en) | 1992-11-12 |
CN1066068A (en) | 1992-11-11 |
IL101627A0 (en) | 1992-12-30 |
YU44592A (en) | 1994-12-28 |
CZ395592A3 (en) | 1994-02-16 |
BR9205939A (en) | 1994-09-27 |
MX9201916A (en) | 1992-11-01 |
EP0590094A1 (en) | 1994-04-06 |
IE921330A1 (en) | 1992-11-04 |
NO933837L (en) | 1993-10-25 |
ZA922976B (en) | 1993-10-25 |
PT100426A (en) | 1993-08-31 |
FI934710A0 (en) | 1993-10-25 |
AU1879792A (en) | 1992-12-21 |
JPH06501025A (en) | 1994-01-27 |
DE9290049U1 (en) | 1994-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL105806A0 (en) | Aminoquinoline derivatives and pharmaceutical compositions containing the same | |
IL102764A0 (en) | Quinazoline derivatives,and pharmaceutical compositions containing them | |
AU638346B2 (en) | Carbostyril derivatives and pharmaceutical composition containing the same | |
GR3023258T3 (en) | 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives | |
IL111221A0 (en) | N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them | |
IL106431A0 (en) | Aminediol derivatives and pharmaceutical compositions containing the same | |
IL103910A0 (en) | New peptide derivatives and pharmaceutical compositions containing them | |
GB9108547D0 (en) | Quinoline derivatives | |
IL105003A0 (en) | Indole derivatives and pharmaceutical compositions containing them | |
IL101865A0 (en) | Thiopyranopyrrole derivatives and their preparation | |
IL99902A0 (en) | Indane and quinoline derivatives and pharmaceutical compositions containing the same | |
EP0498268A3 (en) | 5-oxo-l-proline derivatives and pharmaceutical use thereof | |
NZ227036A (en) | Quinoline derivatives and pharmaceutical compositions containing such | |
NZ228098A (en) | Quinoline derivatives and pharmaceutical compositions | |
ZA921279B (en) | Substituted alpha-aminoaldehydes and derivatives | |
NZ227743A (en) | Isoquinolinone derivatives and their pharmaceutical compositions | |
IL110033A0 (en) | Bis-imide derivatives and pharmaceutical compositions containing them | |
IL104623A0 (en) | Biphenyl-substituted quinoline derivatives and pharmaceutical compositions containing the same | |
IL100850A0 (en) | Indole derivatives and pharmaceutical compositions containing them | |
IL102178A0 (en) | Chroman derivatives and pharmaceutical compositions containing them | |
HU9303025D0 (en) | 4-aryl-3(jheteroaryl-ureido)-quinoline derivatives and pharmaceutical preparatives containing them | |
IL103747A0 (en) | Saccharin derivatives and pharmaceutical compositions containing them | |
IL113975A0 (en) | 3-heteroaliphatyl- and 3-hetero (aryl) aliphatyl-2(1H)- quinolone derivatives and pharmaceutical co mpositions containing same | |
IL98680A0 (en) | Hydroxamate derivatives and pharmaceutical compositions containing them | |
ZA912630B (en) | New ethylene-substituted phenylalkylethylenediamine-platinum(ii or iv)derivatives and phenylalkylethylenediamines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee | ||
DNF4 | Restoration of lapsed final protection | ||
DFC4 | Cancellation of temporary protection due to refusal |